No internet connection — showing the saved version of the page.

DBV Technologies

USUSD
← to the screener

DBV Technologies (LSE:0QAJ) — Biotechnology: Biological Products (No Diagnostic Substances). Number of exchanges where the company shares trade: 3. On this page — price and chart, dividends, top holders and share count history.

About the company

Website
dbv-technologies.com
Investor relations
dbv-technologies.com/investor-overview/
Sector
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Headquarters
CHATILLON, France
CEO
Daniel Tassé
Employees
170
Founded
2002
Shares outstanding
296.06 M as of 2026-07-16
Free float
34.94 M
Market cap
731.56 M USD
Insiders
0%
Institutions
41.66%
Industry (SIC)
Biological Products, (No Diagnostic Substances)
Legal form
K65D
ISIN
FR0010417345
LEI
969500PVBQFWQKVDMD80
FCF
−171 M USD
Debt
510 K USD
net cash
Earnings and FCF — for the 12 months to 30.06.2026 (the company's latest report).
NAV
0.54 USD · P/NAV 3.56
Balance sheet date30.06.2026
Assets223 M USD
− Liabilities62.8 M USD
= NAV (equity of the company's shareholders)160 M USD
= Tangible NAV160 M USD
Shares296 061 497
NAV per share0.54 USD
Tangible NAV per share0.54 USD
Share price (0QAJ)1.6950 EUR
P/NAV3.56
NAV history
Balance sheet dateNAVNAV per share
30.06.2026160 M USD0.54 USD
31.03.2026208 M USD0.70 USD
31.12.2025169 M USD0.57 USD
30.09.202552.9 M USD0.39 USD
30.06.202586.2 M USD0.63 USD
31.03.20252.90 M USD0.03 USD
31.12.202427.4 M USD0.27 USD
30.09.202454.0 M USD0.56 USD
Description

DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products in France. Its product pipeline comprising Viaskin Peanut, an immunotherapy product, which has completed Phase 3 clinical trial for the treatment of peanut allergies; and Viaskin Milk which is in Phase 1/2 clinical trial for the treatment of immunoglobulin E (IgE) mediated or cow's milk protein allergy and eosinophilic esophagitis. The company's earlier stage research programs include celiac disease. In addition, the company develops Viaskin technology platform, a platform to potentially treat food allergy. It has a collaboration with Nestlé Health Science to develop MAG1C, a ready-to-use atopy patch test for the diagnosis of non-IgE mediated CMPA in infants and toddlers. DBV Technologies S.A. was incorporated in 2002 and is headquartered in Châtillon, France.

advertisement

Exchanges and tickers

ExchangeTickerCurrencyPriceType
US USA StocksDBVTF OTCUSD1.98 -10.00%common stock
LSE London Stock Exchange0QAJ IOBEUR1.695 +0.12%common stock
PA Euronext ParisDBV primaryEUR1.587 -0.44%common stock

Price for 3 months

up day down dayHover / tap a day — open, close, high and low prices

Top holders

HolderStakeSharesReport date
MPM Bioimpact LLC5.83%3.67 M2026-06-30
Siren, L.L.C.2.95%1.86 M2026-06-30
Vivo Capital, LLC2.93%1.84 M2026-06-30
Perceptive Advisors Llc2.63%1.65 M2026-06-30
Baker Bros. Advisors, LP2.32%1.46 M2026-06-30
Artisan Partners Limited…2.18%1.37 M2026-06-30
UBS Group AG2.09%1.31 M2026-06-30
Morgan Stanley1.52%954 9082026-06-30
Logos Global Management…1.46%915 0002026-06-30
Patient Square Capital L…1.45%909 4742026-06-30
Artisan Partners Funds I…1.34%840 2512026-06-30
Fidelity Advisor Series…0.68%428 8002026-07-31
iShares Trust-iShares Co…0.3%942 5282026-08-31
MOHIDEEN PHARIS (Officer…≈0.23%144 9952026-01-29
iShares Trust-iShares MS…0.21%666 4802026-08-31
Ikarian Capital, LLC0.19%525 0002025-12-31
RUSSELL INVESTMENT CO-Ta…0.07%45 0892026-04-30
College Retirement Equit…0.04%117 6682026-06-30
RUSSELL INVESTMENT CO-U.…0.04%22 7072026-04-30
Fidelity Salem Street Tr…0.03%108 0802026-07-31
SPDR INDEX SHARES Fd.S-S…0.03%105 2332026-07-31
Fidelity Concord Street…0.02%51 0822026-07-31
Fidelity Concord Street…0.02%12 8552026-07-31
iShares Trust-iShares Co…0.01%41 1822026-08-31
SPDR-EUROPE-SSgA SPDR ET…0.01%36 6502026-07-31
SPDR-EUROPE-SSgA SPDR ET…0.01%28 8542026-07-31
iShares Trust-iShares MS…0.01%19 5272026-08-31
RUSSELL INVESTMENT FUNDS…0.01%5 8342026-06-30
Steward Funds Inc-Stewar…0.01%4 0512026-04-30
LORD ABBETT SECURITIES T…0%2 9732026-04-30
Trust for Professional M…0%2 2452026-05-31
Gabelli Healthcare & Wel…0%4002026-06-30